Pluvia Biotech is a spin-out from the University of Bergen (Norway) dedicated to developing "first in class" oral pharmacological chaperones for the treatment of Phenylketonuria (PKU). Through pioneering research and development, Pluvia Biotech aims to provide PKU patients with the opportunity to live life without the dietary constraints imposed by the condition. The company has significant momentum moving its lead compound towards clinical Proof of Concept.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Thormøhlensgt 51, Bergen,5006,norway
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.pluviabiotech.com
- Keywords
- Bergen.
- HQ
- Bergen
Pluvia Biotech Questions
Pluvia Biotech's website is http://www.pluviabiotech.com
Pluvia Biotech's LinkedIn profile is https://no.linkedin.com/company/pluvia-biotech
Pluvia Biotech has
9 employees.
View email and phone details for 9
employees at Pluvia Biotech.
Pluvia Biotech's industry is
Biotechnology Research
Pluvia Biotech's top competitors are
Vis,
Nordicneurolab,
M Ventures,
Pioneer Research As,
Seald As,
Acesion Pharma,
Miphic (Techstars'24),
Klyv Therapeutics As,
Authera,
Noteless.
Pluvia Biotech's categories are Biotechnology Research
Pluvia Biotech's founding year is 2015
